forgemax.FORGED. TESTED. PROVEN.
injizierbare-steroide — Kategorie Hero
Guides

Sustanon 250 (Testosterone Mix): Cycle, Dosage, and Ester Breakdown

Sustanon 250 blends four testosterone esters into one injection. Learn how to structure a 10–12 week cycle, dose 250–500 mg weekly, manage estradiol, and time your PCT correctly.

Sustanon 250 (Testosterone Mix): Cycle, Dosage, and Ester Breakdown

TL;DR

  • Sustanon 250 is a blend of four testosterone esters per millilitre: 30 mg propionate, 60 mg phenylpropionate, 60 mg isocaproate, and 100 mg decanoate — 250 mg total, which corresponds to roughly 176 mg of actual testosterone once ester weight is accounted for.
  • The standard performance dose is 250–500 mg per week, split into two equal injections (e.g. Monday/Thursday) to smooth out the peak-and-trough pattern the mixed esters create.
  • A typical cycle runs 10–12 weeks, with noticeable training effects arriving around weeks 3–5 once the longer esters saturate.
  • Like any testosterone, Sustanon aromatises to oestradiol — E2 management by bloodwork, not by feel, is the central skill of running it.
  • Because of the decanoate ester, PCT starts roughly 14–18 days after the last injection, not immediately, and typically runs four weeks with a SERM.
  • Bloodwork before, during, and after the cycle is non-negotiable: hormones, oestradiol, lipids, liver enzymes, and haematocrit.

What Sustanon 250 Is

Sustanon 250 is an injectable testosterone preparation originally developed by Organon in the 1970s for testosterone replacement therapy. The design goal was clinical convenience: by combining a fast ester with progressively longer ones, a single monthly injection could (in theory) keep hypogonadal patients in range without the peaks and crashes of short esters alone. In practice, even for TRT the injection interval proved shorter than intended, but the blend became a fixture of European pharmacy shelves and, from there, of performance use.

Pharmacologically, there is nothing exotic here. Once each ester is cleaved by enzymes in the blood and tissue, the active molecule is plain testosterone — the same hormone your body produces, with the anabolic-androgenic ratio of 100:100 against which every other steroid is benchmarked. Everything distinctive about Sustanon is a matter of release kinetics, not of the hormone itself.

Ester Breakdown: What the Four Esters Do

The ester attached to testosterone controls how quickly it leaves the intramuscular depot and enters circulation. Sustanon stacks four of them:

Ester

Amount per ml

Approx. half-life

Role in the blend

Testosterone propionate

30 mg

~2–3 days

Fast onset; raises levels within days

Testosterone phenylpropionate

60 mg

~4–5 days

Bridges the gap after propionate fades

Testosterone isocaproate

60 mg

~6–9 days

Mid-length release over weeks 1–2

Testosterone decanoate

100 mg

~12–15 days

Long tail; drives saturation and slow clearance

Two practical consequences follow. First, ester weight displaces hormone: 250 mg of the blend delivers roughly 176 mg of actual testosterone, slightly less than 250 mg of enanthate. The difference is small but real. Second, the kinetics are not actually smooth. A single weekly injection produces a noticeable spike in the first few days (propionate and phenylpropionate) followed by a decline before the decanoate tail fully compensates. This is why the "one shot per week" schedule that Sustanon's marketing implies is suboptimal — blood levels, and with them oestradiol, swing more than they need to.

The general principle — esters alter release speed, not potency — holds across all anabolic compounds, and it is the same logic used when comparing the long and short esters of boldenone and nandrolone in Equipoise Vs DECA Vs NPP Boldenone And Nandrolone Esters Compared. If you are weighing Sustanon against a single-ester testosterone, the honest summary is that twice-weekly enanthate produces flatter levels with less arithmetic; the full protocol for that alternative is laid out in Testosterone Enanthate Cycle Guide. Sustanon's genuine advantages are pharmaceutical provenance and wide availability in Europe, not superior chemistry.

Dosage and Injection Protocol

Dosage norms in performance contexts cluster into familiar bands:

Experience level

Weekly dose

Injection schedule

Beginner

250–500 mg

2 × per week (e.g. Mon/Thu)

Intermediate

500–750 mg

2 × per week

Advanced

750 mg+

2 × per week

Splitting the weekly dose into two equal injections — for example one 1 ml ampoule (250 mg) on Monday and one on Thursday — is the single most effective way to flatten the blend's uneven release. Some users inject every other day to squeeze more out of the 30 mg propionate fraction; the marginal benefit is small relative to the extra injection burden, and twice weekly is the rational compromise for most.

Two points matter more than the number itself. First, dose-response is not linear: the gain between 250 mg and 500 mg per week is substantial, while jumping from 500 mg to 750 mg adds modest benefit against a disproportionate rise in aromatisation, haematocrit, and blood pressure. Second, higher doses are only defensible when your monitoring scales with them — and few beginners are equipped to monitor a 750 mg cycle properly.

Cycle Plan and PCT Timing

The blend's long esters need time to saturate. Steady state arrives around weeks 3–4, and the tangible effects — climbing strength, faster recovery, persistent pumps — typically land between weeks 3 and 5. A cycle shorter than 10 weeks wastes the saturation phase; beyond 12–14 weeks, suppression burden and lipid/haematocrit drift accumulate faster than returns.

Week

Sustanon 250

Supporting actions

0

—

Baseline bloodwork: hormones, lipids, liver, haematocrit, blood pressure

1–12

2 × 250 mg/week

Training and diet dialled in; AI only if bloodwork demands it

5–6

—

Mid-cycle bloodwork: total T, E2 sensitive, lipids, haematocrit

13–14

None

Ester clearance; levels decline over ~2–2.5 weeks

15/16–19/20

PCT

SERM protocol, e.g. tamoxifen 20 mg/day for 4 weeks

21+

—

Post-PCT bloodwork to confirm recovery

PCT timing is where Sustanon differs meaningfully from short esters and where mistakes are most common. The decanoate tail keeps releasing testosterone for two weeks or more after the final injection; starting SERMs while exogenous hormone is still suppressive wastes them. Begin PCT roughly 14–18 days after the last shot, run a standard four-week SERM protocol, and verify recovery with bloodwork (LH, FSH, total testosterone) three to four weeks after it ends. Skipping PCT entirely risks months of hypogonadal symptoms: lost gains, depressed mood, absent libido.

Side Effects, Risks, and Who Should Not Use It

At 250–500 mg per week with monitoring, Sustanon is among the more manageable anabolic compounds — but manageable is not harmless:

  • Suppression: natural testosterone production shuts down within weeks. This is guaranteed, not probabilistic — hence PCT.
  • Estrogenic effects: testosterone aromatises proportionally to dose. Excess oestradiol brings water retention, rising blood pressure, and gynecomastia risk; early signs (nipple sensitivity, itching, palpable tissue) demand immediate attention because established glandular tissue does not resolve on its own. Crashed oestradiol from overzealous AI use is its own problem — joint pain, flat mood, worsened lipids. Dose any aromatase inhibitor to bloodwork, never prophylactically from day one.
  • Androgenic effects: acne and accelerated hair loss in those genetically predisposed to male-pattern baldness.
  • Cardiovascular strain: HDL suppression, haematocrit elevation via stimulated red-cell production, and potential cardiac remodelling with long-term heavy use.
  • Fertility: sperm production is suppressed during the cycle; recovery usually follows but can take months.
  • Injection risks: the blend's propionate fraction and common carrier oils make post-injection pain somewhat more frequent than with enanthate. Mild soreness for 24–72 hours is normal; worsening pain, redness, warmth, or fever suggests infection and requires medical attention.

Do not run a cycle if you are under roughly 25, if baseline bloodwork shows pre-existing lipid, liver, or haematological abnormalities, if you have uncontrolled hypertension, or if you cannot commit to the monitoring and PCT protocol. If any of these apply, the correct decision is to wait or abstain.

Bloodwork, Monitoring, and Practical Notes

Running testosterone without bloodwork is driving blindfolded. The minimum panel covers three time points — baseline, mid-cycle (week 5–6), and post-PCT — and should include total and free testosterone with LH/FSH, oestradiol on a sensitive assay (the steering wheel for AI decisions), a lipid panel (expect a modest HDL dip and track its recovery), liver enzymes (injectable testosterone is not hepatotoxic, but a baseline matters), haematocrit and haemoglobin (values above roughly 0.54 warrant dose reduction or phlebotomy), and twice-weekly home blood pressure checks.

On the practical side, genuine Sustanon is a pharmacy product with a long paper trail, and pharmaceutical ampoules remain the benchmark against which underground versions are judged. The classic originator presentation is Sustanon 250 250mg/ml 1x1ml Ampoules by Organon, with Sustanon 250 250mg/ml 1x1ml Ampoules by Aspen as another widely distributed pharmaceutical line in European markets; both are 250 mg/ml in single 1 ml ampoules, which makes dosing arithmetic trivial — one ampoule is one 250 mg injection. Multi-ester testosterone blends from various manufacturers, including higher-concentration versions, are grouped in Testosterone Mix for comparison. Ampoules are single-use: draw with a separate needle, inject with a fresh one, rotate sites, and discard any ampoule with cracked glass or cloudy contents.

FAQ

Is Sustanon 250 better than single-ester testosterone?

Not chemically — the active hormone is identical. Sustanon's blend was designed for infrequent TRT injections, a goal it only partially achieves. Run twice weekly, it performs comparably to enanthate; its real advantages are pharmaceutical manufacturing standards and European availability. Single esters produce slightly flatter blood levels at the same schedule and deliver marginally more actual testosterone per milligram, since less mass is lost to ester weight.

How often should you inject Sustanon 250?

Twice per week is the practical standard — for example Monday and Thursday. Once weekly leaves a pronounced spike-and-decline pattern because the fast esters fade long before the decanoate tail compensates, producing unstable oestradiol. Some inject every other day to exploit the propionate fraction, but the added smoothness rarely justifies the extra injections for most users.

How long does Sustanon take to kick in?

The propionate and phenylpropionate esters raise serum levels within days, so it "starts" faster than enanthate alone. However, meaningful steady state still takes three to four weeks as the long esters accumulate, and clear strength and recovery improvements typically appear between weeks 3 and 5. Feeling something early is normal; judging the cycle before week 5 is premature.

Is 250 mg per week enough for a first cycle?

For many beginners, yes — one ampoule per week produces measurable gains with a markedly lower side-effect burden than 500 mg. The counterargument is that 500 mg (two ampoules weekly) delivers clearly stronger results in the same timeframe. Below 250 mg, the guaranteed suppression outweighs the modest anabolic return, so doses under that threshold make little sense for a cycle.

When should PCT start after a Sustanon cycle?

Roughly 14–18 days after the last injection. The decanoate ester keeps releasing suppressive testosterone for over two weeks, so starting SERMs earlier wastes them against still-active exogenous hormone. A typical protocol is four weeks of a SERM such as tamoxifen at 20 mg daily, followed by bloodwork three to four weeks later to confirm that LH, FSH, and testosterone have actually recovered.

Can Sustanon be used for low-dose TRT-style protocols?

It can, and in parts of Europe it remains a prescribed TRT option — though clinical practice has largely shifted toward less frequent or smoother alternatives. For self-directed low-dose use, the same rules apply scaled down: split doses at least twice weekly to avoid the blend's inherent swings, monitor bloodwork, and recognise that any sustained exogenous testosterone suppresses natural production regardless of dose size.

Conclusion

Sustanon 250's reputation rests on pharmaceutical pedigree rather than pharmacological magic: it is testosterone in four release speeds, delivering the same hormone, the same gains, and the same risks as any other testosterone preparation. Run it sensibly — 250–500 mg per week split into two injections, 10–12 weeks, bloodwork at baseline, mid-cycle, and after PCT, oestradiol managed by numbers rather than guesswork, and PCT timed to the decanoate tail around day 14–18 — and it is predictable and manageable. The risks that remain are real regardless of dose discipline: guaranteed suppression, estrogenic and androgenic side effects, cardiovascular and haematological strain, and fertility suppression. Anyone under roughly 25, anyone with abnormal baseline labs, and anyone unwilling to commit to the monitoring protocol should not start. The compound rewards those who treat bloodwork as part of the cycle itself, keeps its promises at modest doses, and invoices the careless later — that equation never changes, whatever the label on the ampoule.